Abstract:Rationale: HSV is one of the most widespread human viral pathogens. HSV-1 infects a large portion of the human population and causes severe diseases. The current clinical treatment for HSV-1 is based on nucleoside analogues, the use of which is limited due to drug resistance, side effects and poor bioavailability. AMPs have been identified as potential antiviral agents that may overcome these limitations. Therefore, we screened anti-HSV-1 peptides from a scorpion-derived AMP library and engineered one candidate into a histidine-rich peptide with significantly improved antiviral activity and development potential. Methods: A venomous gland cDNA library was constructed from the scorpion Euscorpiops validus in the Yunnan Province of China. Six putative AMPs were characterized from this cDNA library, and the synthesized peptides were screened via plaque-forming assays to determine their virucidal potential. Time of addition experiments according to the infection progress of HSV-1 were used to identify the modes of action for peptides of interest. The histidine-rich modification was designed based on structural analysis of peptides by a helical wheel model and CD spectroscopy. Peptide cellular uptake and distribution were measured by flow cytometry and confocal microscopy, respectively. Results: The peptide Eval418 was found to have high clearance activity in an HSV-1 plaque reduction assay. Eval418 exhibited dose-dependent and time-dependent inactivation of HSV-1 and dose-dependent inhibition of HSV-1 attachment to host cells. However, Eval418 scarcely suppressed an established HSV-1 infection due to poor cellular uptake. We further designed and modified Eval418 into four histidine-rich derivative peptides with enhanced antiviral activities and lower cytotoxicities. All of the derivative peptides suppressed established HSV-1 infections. One of these peptides, Eval418-FH5, not only had strong viral inactivation activity and enhanced attachment inhibitory activity but also had high inhibitory activity against intracellular HSV-1, which was consistent with its improved intracellular uptake and distribution as confirmed by confocal microscopy and flow cytometry. Conclusion: We successfully identified an anti-HSV-1 peptide, Eval418, from a scorpion venom peptide library and designed a histidine-rich Eval418 derivative with significantly improved potential for further development as an anti-HSV-1 drug. This successful modification can provide a design strategy to improve the bioavailability, cellular distribution and antiviral activity of peptide agents.

Aescin Inhibits Herpes simplex Virus Type 1 Induced Membrane Fusion

Combined Effect of Basic Antiherpetic Drugs with a New Inhibitor of the Terminase Complex of Herpes Simplex Virus Type 1 in Vero Cell Cultures

Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice

Inhibition of Herpes Simplex Virus by Myricetin Through Targeting Viral Gd Protein and Cellular EGFR/PI3K/Akt Pathway

Elaeocarpus sylvestris var. ellipticus Extract and Its Major Component, Geraniin, Inhibit Herpes Simplex Virus-1 Replication

Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression

Efficacy of Sodium Polyanethol Sulfonate on Herpes Simplex Virus-1 Infection in Vitro.

Mucin‐Inspired Polymeric Fibers for Herpes Simplex Virus Type 1 Inhibition

Inhibitory Activity and Mechanism of Two Scorpion Venom Peptides Against Herpes Simplex Virus Type 1

Inhibition of intercellular adhesion in herpex simplex virus infection by glycyrrhizin

Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons

Adenovirus-mediated RNA interference against herpes simplex virus infection in vitro

Anti-herpes Simplex Virus Activity of Polysaccharides from Eucheuma Gelatinae.

Hsp90 Inhibitors Inhibit the Entry of Herpes Simplex Virus 1 into Neuron Cells by Regulating Cofilin-Mediated F-Actin Reorganization

NSC23766 and Ehop016 Suppress Herpes Simplex Virus-1 Replication by Inhibiting Rac1 Activity.

Ginkgolic acid inhibits fusion of enveloped viruses

Inhibitory effects of baicalein against herpes simplex virus type 1

Ethanol Extract from Artemisia Argyi Leaves Inhibits HSV-1 Infection by Destroying the Viral Envelope.

Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity Against HSV-1

Small Interfering RNA Targeting for Infected‐cell Polypeptide 4 Inhibits Herpes Simplex Virus Type 1 Replication in Retinal Pigment Epithelial Cells

Antiviral activity of temporin-1CEb analogues against gingival infection with herpes simplex virus type 1